Literature DB >> 6977367

Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

C Wedelin, M Björkholm, G Holm, S Ogenstad, B Johansson, H Mellstedt.   

Abstract

One hundred and twenty seven consecutive and previously untreated patients with Hodgkin's disease (HD) (mean age 47 years) from the Stockholm area admitted to Radiumhemmet, Karolinska Hospital, were studied. The age-matched control group consisted of 167 healthy adults. Incorporation of [14C]-dT was measured on Day 1 in unstimulated monocyte-depleted lymphocyte cultures, and on Day 3 in cultures activated by PWM, ConA and PPD, T and B cells were enumerated by surface markers. The patients had significantly decreased relative and total T-cell counts, and the lymphocyte DNA synthesis induced by mitogens and PPD was severely impaired, whilst the spontaneous DNA synthesis was significantly greater than in controls. At follow-up (mean 4 years) 40 patients have died. Deceased patients showed greater spontaneous lymphocyte activation and less response to mitogen and antigen stimulation than the survivors. The 5-year survival of patients with severe lymphocyte impairment was 20%, compared to 80% for the remainder. The lymphocyte tests added prognostic information to that from clinical staging. Disregarding the lack of knowledge of the mechanisms underlying the lymphocyte impairment, we suggest that these relatively simple immunological tests should be included in the clinical evaluation of HD patients and would guide the choice of therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977367      PMCID: PMC2010951          DOI: 10.1038/bjc.1982.9

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Immunodeficiency and prognosis in Hodgkin's disease.

Authors:  M Björkholm; G Holm; H Mellstedt; B Johansson
Journal:  Acta Med Scand       Date:  1975-10

2.  The altered response to skin homografts and to delayed allergens in Hodgkin's disease.

Authors:  W D KELLY; R A GOOD; R L VARCO; M LEVITT
Journal:  Surg Forum       Date:  1958

3.  Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.

Authors:  M de Sousa; A Smithyman; C Tan
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

4.  Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.

Authors:  M W Chase
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

5.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

6.  Impaired lymphocyte function in untreated Hodgkin's disease.

Authors:  R Levy; H S Kaplan
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

7.  Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.

Authors:  R S Brown; H A Haynes; H T Foley; H A Godwin; C W Berard; P P Carbone
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

8.  Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.

Authors:  M Björkholm; G Holm; H Mellstedt; B Johansson; J Askergren; G Söderberg
Journal:  Scand J Haematol       Date:  1977-11

9.  Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted?

Authors:  M Björkholm; G Holm; H Mellstedt
Journal:  Scand J Haematol       Date:  1978-04

10.  Second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos; J C Arseneau; V T DeVita; J Whang-Peng; R E Johnson
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

View more
  5 in total

1.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Clinical and laboratory findings in untreated patients with Hodgkin's disease with special reference to age.

Authors:  C Wedelin; M Björkholm; B Johansson; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

3.  Immune functions and the prognosis of patients with solid tumours.

Authors:  E Nordman; I Lehto; A Toivanen
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Phytohemagglutinin-induced mitotic index in blood lymphocytes: a potential biomarker for breast cancer risk.

Authors:  Ourania Kosti; Celia Byrne; Costanza Cocilovo; Shawna C Willey; Yun-Ling Zheng
Journal:  Breast Cancer (Auckl)       Date:  2010-12-15

5.  Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.

Authors:  U Axdorph; A Porwit-MacDonald; J Sjöberg; G Grimfors; M Ekman; W Wang; P Biberfeld; M Björkholm
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.